Recent developments have raised serious concerns about dietary supplements safety globally. Consequently, the American College of Physicians (ACP) released a position paper advocating for a massive overhaul of the current regulatory framework. In the United States, manufacturers can sell these products as a subcategory of food without prior approval. Similarly, in India, the Food Safety and Standards Authority of India (FSSAI) oversees health supplements under a food-based regulatory system. Therefore, physicians worldwide must understand these gaps to safeguard their patients from mislabeled and adulterated products.
Key Gaps in Dietary Supplements Safety
Currently, regulatory authorities do not require premarket approval for supplements. As a result, harmful and adulterated substances often reach consumers before regulators can act. Furthermore, the lack of standardized clinical trials makes it difficult to verify their efficacy. This regulatory gap poses a significant public health hazard. For example, many products contain hidden pharmaceutical ingredients that cause severe adverse events. Thus, clinicians frequently encounter patients who suffer from unexpected supplement toxicities.
The ACP Policy Recommendations
To address these issues, the ACP proposes ten key policy changes. First, they recommend amending laws to require rigorous, evidence-based premarket review. Additionally, the college urges governments to increase funding for regulatory oversight. This additional funding would strengthen adverse-event reporting databases. Moreover, the ACP advises integrating supplement usage data directly into electronic health records. Consequently, healthcare providers could easily track potential drug-supplement interactions during routine consultations.
Relevance for Doctors in India
Indian physicians must pay close attention to these global discussions. Currently, the nutraceutical industry in India is growing at an exponential rate. However, the FSSAI regulates these products under a food safety framework rather than a pharmaceutical one. As a result, doctors often struggle to find reliable safety data for local formulations. Therefore, adopting a highly proactive clinical approach is essential. Specifically, you should ask patients about their supplement use during every visit. Furthermore, educating patients on the risks of self-prescription can prevent severe drug interactions.
Frequently Asked Questions
Q1: Why is the ACP calling for new regulations on dietary supplements?
The ACP highlights that current laws classify supplements as food, which exempts them from premarket safety and efficacy trials. Consequently, this allows contaminated or mislabeled products to enter the market and endanger public health.
Q2: How does the Indian regulatory system for health supplements compare?
In India, the FSSAI regulates health supplements and nutraceuticals under a food safety framework. Therefore, like the United States, India lacks a strict pharmaceutical-grade premarket approval process for these products.
Q3: What clinical action should physicians take regarding supplement use?
Physicians must actively ask patients about their supplement consumption during clinical visits. Additionally, doctors should integrate this information into electronic medical records to actively monitor for drug-supplement interactions.
References
- Cline K et al. Modernizing the Regulatory Framework for Dietary Supplements: A Position Paper From the American College of Physicians. Ann Intern Med. 2026 Jul 14. doi: 10.7326/ANNALS-26-01119. PMID: 42441966.
- Food Safety and Standards Authority of India (FSSAI). Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food, and Novel Food) Regulations, 2016.
- Nutritional Outlook. The American College of Physicians Proposes Modernizing DSHEA Framework. Published online July 15, 2026.